Skip to content
10-K

Annual Report

TYRA BIOSCIENCES, INC. TYRA

0001193125-26-085490

← back to feed
Filed
Mar 2, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 25, 2026 53.87M sh
Shares Diluted FY 2025 · Dec 31, 2025 59.6M sh
Shares Diluted FY 2025 · Dec 31, 2024 57.22M sh
Capex FY 2025 · Dec 31, 2025 $141K
Capex FY 2025 · Dec 31, 2024 $664K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$95.14M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$69.77M
Cash And Equivalents FY 2025 · Dec 31, 2025 $77.39M
Cash And Equivalents FY 2025 · Dec 31, 2024 $91.97M
Stockholders Equity FY 2025 · Dec 31, 2025 $259.18M
Stockholders Equity FY 2025 · Dec 31, 2024 $343.15M
Stockholders Equity FY 2025 · Dec 31, 2023 $204.26M
Current Liabilities FY 2025 · Dec 31, 2025 $18.09M
Current Liabilities FY 2025 · Dec 31, 2024 $14.59M
Total Liabilities FY 2025 · Dec 31, 2025 $23.43M
Total Liabilities FY 2025 · Dec 31, 2024 $20.41M
Current Assets FY 2025 · Dec 31, 2025 $265.45M
Current Assets FY 2025 · Dec 31, 2024 $347.46M
Total Assets FY 2025 · Dec 31, 2025 $282.61M
Total Assets FY 2025 · Dec 31, 2024 $363.56M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.01
Eps Diluted FY 2025 · Dec 31, 2024 −$1.51
Eps Basic FY 2025 · Dec 31, 2025 −$2.01
Eps Basic FY 2025 · Dec 31, 2024 −$1.51
Rd Expense FY 2025 · Dec 31, 2025 $102.93M
Rd Expense FY 2025 · Dec 31, 2024 $80.08M
Net Income FY 2025 · Dec 31, 2025 −$119.95M
Net Income FY 2025 · Dec 31, 2024 −$86.48M
Operating Income FY 2025 · Dec 31, 2025 −$132.76M
Operating Income FY 2025 · Dec 31, 2024 −$104.18M